tiprankstipranks
Trending News
More News >
Razor Labs Ltd. (IL:RZR)
:RZR
Israel Market
Advertisement

Razor Labs (RZR) AI Stock Analysis

Compare
0 Followers

Top Page

IL:RZR

Razor Labs

(RZR)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 4o)
Rating:42Neutral
Price Target:
384.00
▲(5.81% Upside)
Razor Labs faces significant challenges with profitability and high leverage, impacting its financial performance score. Technical indicators suggest a bearish trend, and valuation is weak due to negative earnings. These factors collectively result in a low overall stock score.
Positive Factors
Revenue Growth
Strong revenue growth indicates expanding market presence and product demand, supporting long-term business sustainability and potential for future expansion.
Cash Flow Improvement
Improved free cash flow growth enhances financial flexibility, allowing for reinvestment in business operations and reducing reliance on external financing.
Diversified Revenue Model
A diversified revenue model reduces dependency on any single income stream, providing stability and resilience against market fluctuations.
Negative Factors
High Leverage
High leverage poses financial risks, potentially limiting the company's ability to invest in growth opportunities and increasing vulnerability to economic downturns.
Negative Profitability
Persistent negative profitability indicates operational inefficiencies, which could hinder long-term sustainability and investor confidence.
Negative Operating Cash Flow
Negative operating cash flow suggests challenges in covering operational expenses, which may necessitate additional financing and impact financial health.

Razor Labs (RZR) vs. iShares MSCI Israel ETF (EIS)

Razor Labs Business Overview & Revenue Model

Company DescriptionRazor Labs operates in the artificial intelligence (AI) industry in Israel. It offers DataMind, an industrial optimization platform to take manufacturing process into a virtual world; and AI pipeline, a video analytics platform to chain together various AI applications into one solution that fit corporate objectives. The company is based in Tel Aviv, Israel.
How the Company Makes MoneyRazor Labs generates revenue through a diversified model that includes project-based consulting fees, subscription services for its proprietary software platforms, and ongoing maintenance contracts with clients. The company also engages in strategic partnerships with industry leaders to co-develop AI solutions, which provides additional revenue opportunities through collaborative projects. Furthermore, Razor Labs may capitalize on licensing its technology to other businesses, creating a steady stream of income from intellectual property. The combination of these revenue streams, along with a focus on expanding its client base and enhancing service offerings, contributes significantly to its earnings.

Razor Labs Financial Statement Overview

Summary
Razor Labs exhibits strong revenue growth but faces significant profitability and cash flow challenges. The company is highly leveraged, which poses financial risks. While there are improvements in cash flow, negative margins and high debt levels require strategic adjustments for financial stability.
Income Statement
30
Negative
Razor Labs shows a strong revenue growth rate of 23.62% in the TTM, indicating potential for future expansion. However, the company struggles with profitability, as evidenced by negative net profit, EBIT, and EBITDA margins. The gross profit margin has improved slightly over time, but the persistent losses highlight significant operational challenges.
Balance Sheet
40
Negative
The company's debt-to-equity ratio has improved from previous years but remains relatively high at 1.56 in the TTM, indicating a leveraged position. Return on equity is negative, reflecting ongoing losses. The equity ratio is not explicitly provided, but the high leverage suggests a need for careful financial management to avoid solvency risks.
Cash Flow
35
Negative
Razor Labs has shown a significant improvement in free cash flow growth, with an 84.50% increase in the TTM. However, operating cash flow remains negative, and the operating cash flow to net income ratio is unfavorable. The free cash flow to net income ratio is positive, indicating some ability to generate cash relative to net losses.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue27.87M17.22M5.29M5.14M14.20M22.30M
Gross Profit12.17M7.14M648.00K1.60M1.91M11.23M
EBITDA-13.84M-10.81M-13.70M-23.32M-36.45M1.50M
Net Income-16.60M-15.48M-18.33M-27.56M-41.57M-7.00K
Balance Sheet
Total Assets55.60M79.93M82.82M71.30M101.22M23.48M
Cash, Cash Equivalents and Short-Term Investments38.22M55.29M58.63M44.52M71.12M2.04M
Total Debt4.89M18.28M20.68M23.23M22.71M11.90M
Total Liabilities52.44M68.77M57.23M28.49M31.34M18.86M
Stockholders Equity3.14M11.14M25.57M42.80M69.88M4.61M
Cash Flow
Free Cash Flow-6.75M-567.00K17.11M-23.98M-36.43M1.27M
Operating Cash Flow-6.51M-308.00K17.25M-23.84M-32.78M1.53M
Investing Cash Flow-15.02M6.96M-7.47M42.34M-45.22M812.00K
Financing Cash Flow-2.83M-2.83M-2.38M-3.17M105.08M-1.19M

Razor Labs Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price362.90
Price Trends
50DMA
387.14
Negative
100DMA
426.34
Negative
200DMA
454.74
Negative
Market Momentum
MACD
-4.64
Negative
RSI
50.93
Neutral
STOCH
54.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:RZR, the sentiment is Neutral. The current price of 362.9 is above the 20-day moving average (MA) of 351.35, below the 50-day MA of 387.14, and below the 200-day MA of 454.74, indicating a neutral trend. The MACD of -4.64 indicates Negative momentum. The RSI at 50.93 is Neutral, neither overbought nor oversold. The STOCH value of 54.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:RZR.

Razor Labs Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
42
Neutral
159.45M-9.08238.35%-0.43%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:RZR
Razor Labs
362.90
-149.50
-29.18%
IL:ORAD
Orad
129.50
63.00
94.74%
IL:SADE
Sade Real Estat
579.00
0.90
0.16%
IL:CLAB
C-Lab
981.80
-74.20
-7.03%
IL:UTRN
Utron
499.60
147.50
41.89%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 28, 2025